This is therefore a contrasting of the analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership in Intec Pharma Ltd. (NASDAQ:NTEC) and Savara Inc. (NASDAQ:SVRA). The two are both Biotechnology companies that compete with one another.
Demonstrates Intec Pharma Ltd. and Savara Inc. earnings per share (EPS), gross revenue and valuation.
Table 2 demonstrates the return on equity, return on assets and net margins of Intec Pharma Ltd. and Savara Inc.
Institutional and Insider Ownership
Roughly 39.64% of Intec Pharma Ltd. shares are held by institutional investors while 50.5% of Savara Inc. are owned by institutional investors. Insiders held roughly 11.81% of Intec Pharma Ltd.’s shares. Competitively, insiders own roughly 1.5% of Savara Inc.’s shares.
In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.